Keyphrases
Randomized Trial
100%
Iodine-125 Brachytherapy
100%
Collaborative Ocular Melanoma Study
100%
Enucleation
80%
Choroidal Melanoma
60%
Radiotherapy
40%
Ophthalmologist
40%
Survival Outcomes
40%
Brachytherapy
40%
Tumor
20%
United States
20%
5-year Survival
20%
Clinical Follow-up
20%
Epidemiologic
20%
Uveal Melanoma
20%
Accruals
20%
Quality of Life Outcomes
20%
Multicenter Randomized Trial
20%
Comparative Effectiveness Trial
20%
Medicine and Dentistry
Iodine 125
100%
Brachytherapy
100%
Eye Melanoma
100%
Enucleation
80%
Choroid Melanoma
60%
Radiation Therapy
40%
Arm
40%
Neoplasm
20%
Observational Study
20%
Quality of Life
20%
Uveal Melanoma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Iodine-125
100%
Eye Melanoma
100%
Choroid Melanoma
60%
Neoplasm
20%
Observational Study
20%
Uvea Melanoma
20%